Anticancer Activity of Curcumin and Its Analogues: Preclinical and Clinical Studies

References

• Mukhtar H, Ahmad N. Cancer chemoprevention: future holds in multiple agents. Toxicol Appl Pharmacol. 1999;158:207–210.
   PubMed Web of Science ®Google Scholar
• Aggarwal BB. The past, present and future of multi-targeted cancer treatment “Naturally”: food for thought. Cancer Lett. 2008;269:187–188.
   PubMed Web of Science ®Google Scholar
• Dahmke IN, Boettcher S P, Groh M, Mahlknecht U. Cooking enhances curcumin anti-cancerogenic activity through pyrolytic formation of “deketene curcumin”. Food Chem. 2014;151:514–519.
   PubMed Web of Science ®Google Scholar
• Lin L, Shi Q, Nyarko AK, Bastow KF, Wu CC, Su CY, et al. Antitumor agents. 250. Design and synthesis of new curcumin analogues as potential anti-prostate cancer agents. J Med Chem. 2006;49:3963–3972
   PubMed Web of Science ®Google Scholar
• Milobedzka J, Kostanecki V, Lampe V. Structure of curcumin. Chem Ber. 1910;43:2163–2167.
   Google Scholar
• Aminul I. Genetic diversity of the genus Curcuma in Bangladesh and further biotechnological approaches for in vitro regeneration and long-term conservation of C. longa germplasm [PhD Thesis]. University of Hannover; 2004.
   Google Scholar
• Warrier PK, Nambiar VPK, Ramankutty C. In: Indian medicinal plants – a compendium of 500 species, (Chennai: Orient Longman Pvt Ltd) 1994:106.
   Google Scholar
• Kirtikar KR, Basu BD In: Indian medicinal plants 2nd edition (Dehra Dun: Bishen Singh Mahendra Pal Singh) 1984:2422–2423.
   Google Scholar
• Mazumder A, Raghavan K, Weinstein J, Kohn KW, Pommier Y. Inhibition of human immunodeficiency virus type-1 integrase by curcumin. Biochem Pharmacol. 1995;49:1165–1170.
   PubMed Web of Science ®Google Scholar
• Anto RJ, George J, Babu KV, Rajasekharan KN, Kuttan R. Antimutagenic and anticarcinogenic activity of natural and synthetic curcuminoids. Mutat Res. 1996;370:127–131.
   PubMed Web of Science ®Google Scholar
• Aggarwal BB, Kumar A, Bharti AC, et al. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res. 2003;23:363–398.
   PubMed Web of Science ®Google Scholar
• Dorai T, Aggarwal BB. Role of chemopreventive agents in cancer therapy. Cancer Lett. 2004;215:129–140.
   PubMed Web of Science ®Google Scholar
• Duvoix A, Blasius R, Delhalle S, Chnekenburger M, Morceau F, Henry E, et al. Chemopreventive and therapeutic effects of curcumin. Cancer Lett. 2005;223:181–190.
   PubMed Web of Science ®Google Scholar
• Olszanecki R, Jawień J, Gajda M, Mateuszuk L, Gebska A, Korabiowska M, et al. Effect of curcumin on atherosclerosis in apoE/LDLR-double knockout mice. J Physiol Pharmacol. 2005;56:627–635.
   PubMed Web of Science ®Google Scholar
• Park BS, Kim JG, Kim MR, Lee SE, Takeoka GR, Oh KB, et al. Curcuma longa L. constituents inhibit sortase A and Staphylococcus aureus cell adhesion to fibronectin. J Agric Food Chem. 2005;53:9005–9009.
   PubMed Web of Science ®Google Scholar
• Alpers DH. The potential use of curcumin in management of chronic disease: too good to be true?. Curr Opin Gastroent. 2008;24:173–175.
   PubMed Web of Science ®Google Scholar
• Goel A. Curcumin as “Curecumin”: from kitchen to clinic. Biochem Pharmacol. 2008;75:787–809.
   PubMed Web of Science ®Google Scholar
• Da Lozzo EJ, Moledo RC, Faraco CD, Ortolani-Machado CF, Bresolin TM, Silveira JL. Curcumin/xanthan-galactomannan hydrogels: rheological analysis and biocompatibility. Carbohydr Polym. 2013;93:279–284.
   PubMed Web of Science ®Google Scholar
• Strimpakos AS, Sharma RA. Curcumin: preventive and therapeutic properties in laboratory studies and clinical trials. Antioxid Redox Signal. 2008;10:511–545.
   PubMed Web of Science ®Google Scholar
• Mimeault M, Batra SK. Potential applications of curcumin and its novel synthetic analogs and nanotechnology-based formulations in cancer prevention and therapy. Chin Med. 2011;6:31.
   PubMed Web of Science ®Google Scholar
• BennyM, Antony B. Bioavailability of (BCM-095™). Spice India. 2006;19:1–51.
   Google Scholar
• Sandur SK, Pandey MK, Sung B, Ahn KS, Murakami A, Sethi G, et al. Curcumin, demethoxycurcumin, bisdemothoxycurcumin, tetrahydrocurcumin, and turmerones differentially regulate anti-inflammatory and antiproliferative responses through a ROS-independent mechanism. Carcinogenesis. 2007;8:1765–1773.
   Web of Science ®Google Scholar
• Sharma RA, Steward WP, Gescher AJ. Pharmacokinetics and pharmacodynamics of curcumin. Adv Exp Med Biol. 2007;4:453–470.
   Google Scholar
• Liang S, Ji HF. The pharmacology of curcumin: is it the degradation products? Trends Mol Med. 2012;18:138–143.
   PubMed Web of Science ®Google Scholar
• Metzler M, Pfeiffer E, Schulz SI, Dempe JS. Curcumin uptake and metabolism. Biofactors 2013;39:14–20.
   PubMed Web of Science ®Google Scholar
• Wang K, Qiu F. Curcuminoid metabolism and its contribution to the pharmacological effects. Curr Drug Metab. 2013;14:791–806.
   PubMed Web of Science ®Google Scholar
• Jiang JL, Li ZD, Zhang H, Li Y, Zhang XH, Yuan YF, et al. Feature selection for the identification of antitumor compounds in the alcohol total extracts of Curcuma longa. Planta Med. 2014;80:1036–1044.
   PubMed Web of Science ®Google Scholar
• Thangapazham RL, Sharma A, Maheshwari RK. Multiple molecular targets in cancer chemoprevention by curcumin. AAPS J. 2006;8:E443–E449.
   PubMed Web of Science ®Google Scholar
• Anthwal A, Singh K, Rawat MS, Tyagi AK, Haque A, Ali I, et al. Synthesis of 4-piperidone based curcuminoids with anti-inflammatory and anti-proliferation potential in human cancer cell lines. Anticancer Agents Med Chem. 2016;16:841–851.
   PubMed Web of Science ®Google Scholar
• Buduma K, Chinde S, Dommati AK, Sharma P, Shukla A, Srinivas KV, et al. Synthesis and evaluation of anticancer and antiobesity activity of 1-ethoxy carbonyl-3,5-bis (3′-indolyl methylene)-4-pyperidone analogs. Bioorg Med Chem Lett. 2016;26:1633–1638.
   PubMed Web of Science ®Google Scholar
• Kunwar A, Barik A, Mishra B, Rathinasamy K, Pandey R, Priyadarsini KI. Quantitative cellular uptake, localization and cytotoxicity of curcumin in normal and tumor cells. Biochim Biophys Acta. 2008;1780:673–679.
   PubMed Web of Science ®Google Scholar
• Syng-Ai C, Kumari AL, Khar A. Effect of curcumin on normal and tumor cells: role of glutathione and bcl-2. Mol Cancer Ther. 2004;3:1101–1108.
   PubMed Web of Science ®Google Scholar
• Ravindran J, Prasad S. B.B. Curcumin and Cancer Cells: how many ways can curry kill tumor cells selectively? AAPS J. 2009;11:495–510.
   PubMed Web of Science ®Google Scholar
• Shanmugam MK, Rane G, Kanchi MM, Arfuso F, Chinnathambi A, Zayed ME, et al. The multifaceted role of curcumin in cancer prevention and treatment. Molecules. 2015;20:2728–2769.
   PubMed Web of Science ®Google Scholar
• Wilken R, Veena MS, Wang MB, Srivatsan ES. Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma. Mol Cancer. 2011;10:12.
   PubMed Web of Science ®Google Scholar
• Singh S, Aggarwal BB. Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane). J. Biol. Chem. 1995;270:24995–25000.
   PubMed Web of Science ®Google Scholar
• Hussain AR, Ahmed M, Al-Jomah NA, Khan AS, Manogaran P, Sultana M, et al. Curcumin suppresses constitutive activation of nuclear factor-kappa B and requires functional Bax to induce apoptosis in Burkitt's lymphoma cell lines. Mol Cancer Ther. 2008;7:3318–3329.
   PubMed Web of Science ®Google Scholar
• Lee KH, Chow YL, Sharmili V. BDMC33, a curcumin derivative suppresses inflammatory responses in macrophage-like cellular system: Role of inhibition in NF-κB and MAPK signaling pathways. Int J Mol Sci. 2012;13:2985–3008.
   PubMed Web of Science ®Google Scholar
• Lin JK. Molecular targets of curcumin. Adv Exp Med Biol. 2007;595:227–243.
   PubMed Web of Science ®Google Scholar
• Conboy L. Curcumin-induced degradation of PKC delta is associated with enhanced dentate NCAM PSA expression and spatial learning in adult and aged Wistar rats. Biochem Pharmacol. 2009;77:1254–1265.
   PubMed Web of Science ®Google Scholar
• Bai QX, Zhang XY. Curcumin enhances cytotoxic effects of bortezomib in human multiple myeloma H929 Cells: potential roles of NF-κB/JNK. Int J Mol Sci. 2012;13:4831–4838.
   PubMed Web of Science ®Google Scholar
• Zheng M, Ekmekcioglu S, Walch ET, Tang CH, Grimm EA. Inhibition of nuclear factor-jB and nitric oxide by curcumin induces G2/M cell cycle arrest and apoptosis in human melanoma cells. Melanoma Res. 2004;14:165–171.
   PubMed Web of Science ®Google Scholar
• Buettner R, Mora LB, Jove R. Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention. Clin Cancer Res. 2002;8:945–954.
   PubMed Web of Science ®Google Scholar
• Han YM, Shin DS, Lee YJ, Ismail IA, Hong SH, Han DC, et al. 2-Hydroxycurcuminoid induces apoptosis of human tumor cells through the reactive oxygen species-mitochondria pathway. Bioorg Med Chem Lett. 2011;21:747–751.
   PubMed Web of Science ®Google Scholar
• Corvinus FM, Orth C, Moriggl R, Tsareva SA, Wagner S, Pfitzner EB, et al. Persistent STAT3 activation in colon cancer is associated with enhanced cell proliferation and tumor growth. Neoplasia. 2005;7:545–555.
   PubMed Web of Science ®Google Scholar
• Kusaba T, Nakayama T, Yamazumi K, Yakata Y, Yoshizaki A, Nagayasu T, et al. Expression of p-STAT3 in human colorectal adenocarcinoma and adenoma, correlation with clinicopathological factors. J Clin Pathol. 2005;58:833–838.
   PubMed Web of Science ®Google Scholar
• Catlett-Falcone R, Landowski TH, Oshiro MM, Turkson J, Levitzki A, Savino R, et al. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity. 1999;10:105–115.
   PubMed Web of Science ®Google Scholar
• Li WC, Ye SL, Sun RX, Liu YK, Tang ZY, Kim Y, et al. Inhibition of growth and metastasis of human hepatocellular carcinoma by antisense oligonucleotide targeting signal transducer and activator of transcription 3. Clin Cancer Res. 2006;12:7140–7148.
   PubMed Web of Science ®Google Scholar
• Aggarwal B, Shishodia S. Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol. 2006;71:1397–1421.
   PubMed Web of Science ®Google Scholar
• Lin L, Deangelis S, Foust E, Fuchs J, Li C, Li PK, et al. A novel small molecule inhibits STAT3 phosphorylation and DNA binding activity and exhibits potent growth suppressive activity in human cancer cells. Mol Cancer. 2010;9:217.
   PubMed Web of Science ®Google Scholar
• Chung S, Vadgama JV. Curcumin and epigallocatechin gallate inhibit the cancer stem cell phenotype via down-regulation of STAT3-NFκB signaling. Anticancer Res. 2015;35:39–46.
   PubMed Web of Science ®Google Scholar
• Uehara Y, Inoue M, Fukuda K, Yamakoshi H, Hosoi Y, Kanda H, et al. Inhibition of β-catenin and STAT3 with a curcumin analog suppresses gastric carcinogenesis in vivo. Gastric Cancer. 2015; 18:774–783.
   PubMed Web of Science ®Google Scholar
• Hu A, Huang JJ, Jin XJ, Li JP, Tang YJ, Huang XF, et al. Curcumin suppresses invasiveness and vasculogenic mimicry of squamous cell carcinoma of the larynx through the inhibition of JAK-2/ STAT-3 signaling pathway. Am J Cancer Res. 2014;5:278–288.
   PubMed Web of Science ®Google Scholar
• Wu J, Lu WY, Cui LL. Inhibitory Effect of Curcumin on Invasion of Skin Squamous Cell Carcinoma A431 Cells. Asian Pac J Cancer Prev. 2015;16:2813–2818.
   PubMedGoogle Scholar
• Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature. 2001;414:105–111.
   PubMed Web of Science ®Google Scholar
• Kakarala M, Brenner DE, Korkaya H, Cheng C, Tazi K, Ginestier C, et al. Targeting breast stem cells with the cancer preventive compounds curcumin and piperine. Breast Cancer Res Treat. 2009;122:777–785.
   PubMed Web of Science ®Google Scholar
• Jaiswal AS, Marlow BP, Gupta N, Narayan S. Beta-catenin-mediated transactivation and cell-cell adhesion pathways are important in curcumin (diferuylmethane)-induced growth arrest and apoptosis in colon cancer cells. Oncogene. 2002;21:8414–8427.
   PubMed Web of Science ®Google Scholar
• Elamin MH, Shinwari Z, Hendrayani SF, Al-Hindi H, Al-Shail E, Khafaga Y, et al. Curcumin inhibits the Sonic Hedgehog signaling pathway and triggers apoptosis in medulloblastoma cells. Mol Carcinog. 2009;49:302–314.
   Web of Science ®Google Scholar
• Dandawate P, Padhye S, Ahmad A, Sarkar FH. Novel strategies targeting cancer stem cells through phytochemicals and their analogs. Drug Deliv Transl Res. 2013;3:165–182.
   PubMed Web of Science ®Google Scholar
• Dubrovska A, Elliott J, Salamone RJ, Kim S, Aimone LJ, Walker JR, et al. Combination therapy targeting both tumor-initiating and differentiated cell populations in prostate carcinoma. Clin Cancer Res. 2010;16:5692–5702.
   PubMed Web of Science ®Google Scholar
• Johnson SM, Gulhati P, Arrieta I, Wang X, Uchida T, Gao T, et al. Curcumin inhibits proliferation of colorectal carcinoma by modulating Akt/mTOR signaling. Anticancer Res. 2009;29:3185–3190.
   PubMed Web of Science ®Google Scholar
• Chaudhuri J, Chowdhury AA, Biswas N. Superoxide activates mTOR-eIF4E-Bax route to induce enhanced apoptosis in leukemic cells. Apoptosis. 2014;19:135–148.
   PubMed Web of Science ®Google Scholar
• Beevers CS, Chen L, Liu L, Luo Y, Webster NJ, Huang S. Curcumin disrupts the Mammalian target of rapamycin-raptor complex. Cancer Res. 2009;69:1000–1008.
   PubMed Web of Science ®Google Scholar
• Ryu MJ, Cho M, Song JY, Yun YS, Choi IW, Kim DE, et al. Natural derivatives of curcumin attenuate the Wnt/beta-catenin pathway through down-regulation of the transcriptional coactivator p300. Biochem Biophys Res Commun. 2008;377:1304–1308.
   PubMed Web of Science ®Google Scholar
• Yan C, Jamaluddin MS, Aggarwal B, Myers J, Boyd DD. Gene expression profiling identifies activating transcription factor 3 as a novel contributor to the proapoptotic effect of curcumin. Mol Cancer Ther. 2005;4:233–241.
   PubMed Web of Science ®Google Scholar
• Slusarz A, Shenouda NS, Sakla MS, Drenkhahn SK, Narula AS, MacDonald RS, et al. Common botanical compounds inhibit the hedgehog signaling pathway in prostate cancer. Cancer Res. 2010;70:3382–3390.
   PubMed Web of Science ®Google Scholar
• Lim KJ, Bisht S, Bar EE, Maitra A, Eberhart CG. A polymeric nanoparticle formulation of curcumin inhibits growth, clonogenicity and stem-like fraction in malignant brain tumors. Cancer Biol Ther. 2011;11:464–473.
   PubMed Web of Science ®Google Scholar
• Ramasamy TS, Ayob AZ, Myint HH, Thiagarajah S, Amini F. Targeting colorectal cancer stem cells using curcumin and curcumin analogues: insights into the mechanism of the therapeutic efficacy. Cancer Cell Int. 2015;15:96.
   PubMed Web of Science ®Google Scholar
• Wright LE, Frye JB, Lukefahr AL, Timmermann BN, Mohammad KS, Guise TA, et al. Curcuminoids block TGF-β signaling in human breast cancer cells and limit osteolysis in a murine model of breast cancer bone metastasis. J Nat Prod. 2013;76:316–321.
   PubMed Web of Science ®Google Scholar
• Zhang P, Liegeois NJ, Wong C, Finegold M, Hou H, Thompson JC, et al. Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith-Wiedemann syndrome. Nature 1997;387:151–158.
   PubMed Web of Science ®Google Scholar
• Rao KVK, Samikkannu T, Dakshayani KB, et al. Chemopreventive potential of an ethyl acetate fraction from curcuma longa is associated with upregulation of p57kip2 and Rad9 in the PC-3M prostate cancer cell line. Asian Pacific J Cancer Prev. 2012;13:1031–1038.
   PubMedGoogle Scholar
• Jee SH, Shen SC, Tseng CR, Chiu HC, Kuo ML. Curcumin induces a p53-dependent apoptosis in human basal cell carcinoma cells. J. Investig. Dermatol. 1998;111:656–661.
   PubMed Web of Science ®Google Scholar
• Choudhuri T, Pal S, Agwarwal ML, Das T, Sa G. Curcumin induces apoptosis in human breast cancer cells through p53-dependent Bax induction. FEBS Lett. 2002;512:334–340.
   PubMed Web of Science ®Google Scholar
• Liontas A, Yeger H. Curcumin and resveratrol induce apoptosis and nuclear translocation and activation of p53 in human neuroblastoma. Anticancer Res. 2004;24:987–998.
   PubMed Web of Science ®Google Scholar
• Choudhuri T, Pal S, Das T, Sa G. Curcumin selectively induces apoptosis in deregulated cyclin D1-expressed cells at G2 phase of cell cycle in a p53-dependent manner. J. Biol. Chem. 2005;280:20059–20068.
   PubMed Web of Science ®Google Scholar
• Song G, Mao YB, Cai QF, Yao LM, Ouyang GL, Bao SD. Curcumin induces human HT-29 colon adenocarcinoma cell apoptosis by activating p53 and regulating apoptosis-related protein expression. Braz. J. Med. Biol. Res. 2005;38:1791–1798.
   PubMed Web of Science ®Google Scholar
• Howells LM, Mitra A, Manson MM. Comparison of oxaliplatin- and curcumin-mediated antiproliferative effects in colorectal cell lines. Int. J. Cancer 2007;121:175–183.
   PubMed Web of Science ®Google Scholar
• Shi M, Cai Q, Yao L, Mao Y, Ming Y, Ouyang G. Antiproliferation and apoptosis induced by curcumin in human ovarian cancer cells. Cell Biol. Int. 2006;30:221–226.
   PubMed Web of Science ®Google Scholar
• Wu J, Tang Q, Zhao S, Zheng F, Wu Y, Tang G, et al. Extracellular signal-regulated kinase signaling-mediated induction and interaction of FOXO3a and p53 contribute to the inhibition of nasopharyngeal carcinoma cell growth by curcumin. Int. J. Oncol. 2014;45:95–103.
   PubMed Web of Science ®Google Scholar
• Amin ARMR, Haque A, Rahman MA, et al. Curcumin induces apoptosis of upper aerodigestive tract cancer cells by targeting multiple pathways. PLoS One. 2015;10:e0124218.
   PubMed Web of Science ®Google Scholar
• Mori H, Niwa K, Zheng Q, Yamada Y, Sakata K, Yoshimi N. Cell proliferation in cancer prevention; effects of preventive agents on estrogen-related endometrial carcinogenesis model and on an in vitro model in human colorectal cells. Mutat Res. 2001;480–481:201–207.
   PubMed Web of Science ®Google Scholar
• Hatcher H, Planalp R, Cho J, Torti FM, Torti SV. Curcumin: from ancient medicine to current clinical trials. Cell Mol Life Sci. 2008;65:1631–1652.
   PubMed Web of Science ®Google Scholar
• Jackson SJ, Murphy LL, Venema RC, Singletary KW, Young AJ. Curcumin binds tubulin, induces mitotic catastrophe, and impedes normal endothelial cell proliferation. Food Chem Toxicol. 2013;60:431–438.
   PubMed Web of Science ®Google Scholar
• Anuchapreeda S, Tima S, Duangrat C, Limtrakul P. Effect of pure curcumin, demethoxycurcumin, and bisdemethoxycurcumin on WT1 gene expression in leukemic cell lines. Cancer Chemother Pharmacol. 2008;62:585–594.
   PubMed Web of Science ®Google Scholar
• Parsai S, Keck R, Skrzypczak-Jankun E, Jankun J. Analysis of the anticancer activity of curcuminoids, thiotryptophan and 4-phenoxyphenol derivatives. Oncol Lett. 2014;7:17–22.
   PubMed Web of Science ®Google Scholar
• Kim TD, Fuchs JR, Schwartz E, Abdelhamid D, Etter J, Berry WL, et al. Pro-growth role of the JMJD2C histone demethylase in HCT-116 colon cancer cells and identification of curcuminoids as JMJD2 inhibitors. Am J Transl Res. 2014;6:236–247.
   PubMed Web of Science ®Google Scholar
• Teiten MH, Dicato M, Diederich M. Curcumin as a regulator of epigenetic events. Mol Nutr Food Res. 2013;57:1619–1629.
   PubMed Web of Science ®Google Scholar
• Liu YL, Yang HP, Gong L. Hypomethylation effects of curcumin, demethoxycurcumin and bisdemethoxycurcumin on WIF-1 promoter in non-small cell lung cancer cell lines. Mol Med Rep. 2011;4:675–679.
   PubMed Web of Science ®Google Scholar
• Bhaumik S, Jyothi MD, Khar A. Differential modulation of nitric oxide production by curcumin in host macrophages and NK cells. FEBS Lett. 2000;483:78–82.
   PubMed Web of Science ®Google Scholar
• Jagetia GC, Aggarwal BB. “Spicing up” of the immune system by curcumin. J Clin Immunol. 2007;27:19–35.
   PubMed Web of Science ®Google Scholar
• Yue GG, Chan BC, Hon PM, Lee MY, Fung KP, Leung PC, et al. Evaluation of in vitro anti-proliferative and immunomodulatory activities of compounds isolated from Curcuma longa. Food Chem Toxicol. 2010;48:2011–2020.
   PubMed Web of Science ®Google Scholar
• Gonda R, Tomoda M, Ohara N, Takada K. Arabinogalactan core structure and immunological activities of ukonan C, an acidic polysaccharide from the rhizome of Curcuma longa. Biol Pharm Bull. 1993;16:235–238.
   PubMed Web of Science ®Google Scholar
• Kim AJ, Kim YO, Shim JS, Hwang JK. Immunostimulating activity of crude polysaccharide extract isolated from Curcuma xanthorrhiza Roxb. Biosci Biotechnol Biochem. 2007;71:1428–1438.
   PubMed Web of Science ®Google Scholar
• Kim KI, Shin KS, Jun WJ, Hong BS, Shin DH, Cho HY. Effects of polysaccharides from rhizomes of Curcuma zedoaria on macrophage functions. Biosci Biotechnol Biochem. 2001;65:2369–2377.
   PubMed Web of Science ®Google Scholar
• Yue GG, Chan BC, Hon PM, Kennelly EJ, Yeung SK, Cassileth BR, et al. Immunostimulatory activities of polysaccharide extract isolated from Curcuma longa. Int J Biol Macromol. 2010;47:342–347.
   PubMed Web of Science ®Google Scholar
• Ji JL, Huang XF, Zhu HL. Curcumin and its formulations: potential anti-cancer agents. Anticancer Agents Med Chem. 2012;12:210–218.
   PubMed Web of Science ®Google Scholar
• Chang CC, Fu CF, Yang WT, Chen TY, Hsu YC. The cellular uptake and cytotoxic effect of curcuminoids on breast cancer cells. Taiwan J Obstet Gynecol. 2012;51:368–374.
   PubMed Web of Science ®Google Scholar
• Shieh JM, Chen YC, Lin YC. Demethoxycurcumin inhibits energy metabolic and oncogenic signaling pathways through AMPK activation in triple-negative breast cancer cells. J Agric Food Chem. 2013;61:6366–6375.
   PubMed Web of Science ®Google Scholar
• Ferreira LC, Arbab AS, Jardim-Perassi BV, Borin TF, Varma NR, Iskander AS, et al. Effect of curcumin on pro-angiogenic factors in the xenograft model of breast cancer. Anticancer Agents Med Chem. 2015; 15:1285–1296.
   Web of Science ®Google Scholar
• Singletary K, MacDonald C, Wallig M, Fisher C. Inhibition of 7,12-dimethylbenz[a]anthracene (DMBA)-induced mammary tumorigenesis and DMBA-DNA adduct formation by curcumin. Cancer Lett. 1996;103:137–141.
   PubMed Web of Science ®Google Scholar
• Ushida J, Sugie S, Kawabata K, Pham QV, Tanaka T, Fujii K, et al. Chemopreventive effect of curcumin on N-nitrosomethylbenzylamine-induced esophageal carcinogenesis in rats. Jpn J Cancer Res. 2000;91:893–898.
   PubMedGoogle Scholar
• Gehani N, Katz A. Therapeutic potential of curcumin in human prostate cancer-I. curcumin induces apoptosis in both androgen-dependent and androgen-independent prostate cancer cells. Prostate Cancer Prostatic Dis. 2000;3:84–93.
   PubMed Web of Science ®Google Scholar
• Shehzad A, Wahid F, Lee YS. Curcumin in cancer chemoprevention: molecular targets, pharmacokinetics, bioavailability, and clinical trials. Arch Pharm (Weinheim) 2010;343:489–499.
   PubMed Web of Science ®Google Scholar
• Hung CM, Su YH, Lin HY. Demethoxycurcumin modulates prostate cancer cell proliferation via AMPK-induced down-regulation of HSP70 and EGFR. J Agric Food Chem. 2012;60:8427–8434.
   PubMed Web of Science ®Google Scholar
• Yang CH, Yue J, Sims M, Pfeffer LM. The curcumin analog EF24 Targets NF-κB and miRNA-21, and has potent anticancer activity in vitro and in vivo. PLoS One. 2013;8:e71130.
   PubMed Web of Science ®Google Scholar
• Chen QY, Lu GH, Wu YQ, Zheng Y, Xu K, Wu LJ, et al. Curcumin induces mitochondria pathway mediated cell apoptosis in A549 lung adenocarcinoma cells. Oncol Rep. 2010;23:1285–1292.
   PubMed Web of Science ®Google Scholar
• Wu SH, Hang LW, Yang JS, Chen HY, Lin HY, Chiang JH, et al. Curcumin induces apoptosis in human non-small cell lung cancer NCI-H460 cells through ER stress and caspase cascade- and mitochondria-dependent pathways. Anticancer Res. 2010;30:2125–2133.
   PubMed Web of Science ®Google Scholar
• Kim KC, Baek SH, Lee C. Curcumin-induced downregulation of Axl receptor tyrosine kinase inhibits cell proliferation and circumvents chemoresistance in non-small lung cancer cells. Int J Oncol. 2015;47:2296–2303.
   PubMed Web of Science ®Google Scholar
• Diez JJ, Iglesias P. The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol 2003;148:293–300.
   PubMed Web of Science ®Google Scholar
• Tsai JR, Liu PL, Chen YH, Chou SH, Cheng YJ, Hwang JJ, et al. Curcumin inhibits non-small cell lung cancer cells metastasis through the Adiponectin/NF-κb/MMPs signaling pathway. PLoS One 2015;10:e0144462.
   Web of Science ®Google Scholar
• Chan WH, Wu HY, Chang WH. Dosage effects of curcumin on cell death types in a human osteoblast cell line. Food Chem Toxicol. 2006;44:1362–1371.
   PubMed Web of Science ®Google Scholar
• Jin S, Xu HG, Shen JN, Chen XW, Wang H, Zhou JG. Apoptotic effects of curcumin on human osteosarcoma U2OS cells. Orthop Surg. 2009;1:144–152.
   PubMedGoogle Scholar
• Khaw AK, Hande MP, Kalthur G, Hande MP. Curcumin inhibits telomerase and induces telomere shortening and apoptosis in brain tumour cells. J Cell Biochem. 2013;114:1257–1270.
   PubMed Web of Science ®Google Scholar
• Chang R, Sun L, Webster TJ. Short communication: selective cytotoxicity of curcumin on osteosarcoma cells compared to healthy osteoblasts. Int J Nanomedicine. 2014;9:461–465.
   PubMed Web of Science ®Google Scholar
• Sanabria-Ríos DJ, Rivera-Torres Y, Rosario J, et al. Synthesis of novel C5-curcuminoid-fatty acid conjugates and mechanistic investigation of their anticancer activity. Bioorg Med Chem Lett. 2015;25:2174–2180.
   PubMed Web of Science ®Google Scholar
• Perkins S, Verschoyle RD, Hill K, Parveen I, Threadgill MD, Sharma RA, et al. Chemopreventive efficacy and pharmacokinetics of curcumin in the min/+ mouse, a model of familial adenomatous polyposis. Cancer Epidemiol Biomarkers Prev. 2002;11:535–540.
   PubMed Web of Science ®Google Scholar
• Sreepriya M, Bali G. Effects of administration of Embelin and Curcumin on lipid peroxidation, hepatic glutathione antioxidant defense and hematopoietic system during N-nitrosodiethylamine/ Phenobarbital-induced hepatocarcinogenesis in Wistar rats. Mol Cell Biochem. 2006;284:49–55.
   PubMed Web of Science ®Google Scholar
• Zhang JY, Lin MT, Zhou MJ, Yi T, Tang YN, Tang SL, et al. Combinational treatment of curcumin and quercetin against gastric cancer MGC-803 Cells in Vitro. Molecules 2015;20:11524–11534.
   PubMed Web of Science ®Google Scholar
• Zou P, Xia Y, Chen T, Zhang J, Wang Z, Chen W, et al. Selective killing of gastric cancer cells by a small molecule targeting ROS-mediated ER stress activation. Mol Carcinog. 2016;55:1073–1086.
   Web of Science ®Google Scholar
• Loch-Neckel G, Santos-Bubniak L, Mazzarino L, Jacques AV, Moccelin B, Santos-Silva MC, et al. Orally administered chitosan-coated polycaprolactone nanoparticles containing curcumin attenuate metastatic melanoma in the lungs. J Pharm Sci. 2015;104(10):3524–3534.
   PubMed Web of Science ®Google Scholar
• Yu T, Chen C, Sun Y, Sun H, Li TH, Meng J, et al. ABT-737 sensitizes curcumin-induced anti-melanoma cell activity through facilitating mPTP death pathway. Biochem Biophys Res Commun. 2015;464:286–291.
   PubMed Web of Science ®Google Scholar
• Huang TY, Tsai TH, Hsu CW, Hsu YC. Curcuminoids suppress the growth and induce apoptosis through caspase-3-dependent pathways in glioblastoma multiforme (GBM) 8401 cells. J Agric Food Chem. 2010;58:10639–10645.
   PubMed Web of Science ®Google Scholar
• Bharti AC, Donato N, Singh S, Aggarwal BB. Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-KB and IKBa kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis. Blood 2003;101:1053–1062.
   PubMed Web of Science ®Google Scholar
• Bharti AC, Takada Y, Aggarwal BB. Curcumin (diferuloylmethane) inhibits receptor activator of NF-κB ligand-induced NF-κB activation in osteoclast precursors and suppresses osteoclastogenesis. J Immunol. 2004;172:5940–5947.
   PubMed Web of Science ®Google Scholar
• Golombick T, Diamond TH, Manoharan A, Ramakrishna R. Monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and curcumin: A randomized, double-blind placebo controlled cross-over 4 g study and an open-label 8 g extension study. Am. J. Hematol. 2012;87:455–460.
   PubMed Web of Science ®Google Scholar
• Yang H, Landis-Piwowar KR, Chen D, Milacic V, Dou QP. Natural compounds with proteasome inhibitory activity for cancer prevention and treatment. Curr Prot Peptide Sci. 2008;9:227–239.
   PubMed Web of Science ®Google Scholar
• Milacic V, Banerjee S, Landis-Piwowar KR, Sarkar FH, Majumdar AP, Dou QP. Curcumin inhibits the proteasome activity in human colon cancer cells in vitro and in vivo. Cancer Res. 2008;68:7283–7292.
   PubMed Web of Science ®Google Scholar
• Wan SB, Yang H, Zhou Z, Cui QC, Chen D, Kanwar J, et al. Evaluation of curcumin acetates and amino acid conjugates as proteasome inhibitors. Int J Mol Med. 2010;26:447–455.
   PubMed Web of Science ®Google Scholar
• Mujtaba T, Kanwar J, Wan SB, Chan TH, Dou QP. Sensitizing human multiple myeloma cells to the proteasome inhibitor bortezomib by novel curcumin analogs. Int J Mol Med. 2012;29:102–106.
   PubMed Web of Science ®Google Scholar
• Park J, Ayyappan V, Bae EK, Lee C, Kim BS, Kim BK, et al. Curcumin in combination with bortezomib synergistically induced apoptosis in human multiple myeloma U266 cells. Mol Oncol. 2008;2:317–326.
   PubMed Web of Science ®Google Scholar
• Sung B, Kunnumakkara AB, Sethi G, Anand P, Guha S, Aggarwal BB. Curcumin circumvents chemoresistance in vitro and potentiates the effect of thalidomide and bortezomib against human multiple myeloma in nude mice model. Mol Cancer Ther. 2009;8:959–970.
   PubMed Web of Science ®Google Scholar
• Zhang XY, Bai QX, Huang GS. Effect of curcumin in combination with bortezomib on proliferation and apoptosis of human multiple myeloma cell line H929 and its mechanism. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2011;19:684–688.
   PubMedGoogle Scholar
• Liu K, Zhang D, Chojnacki J, et al. Design and biological characterization of hybrid compounds of curcumin and thalidomide for multiple myeloma. Org Biomol Chem. 2013;11:4757–4763.
   PubMed Web of Science ®Google Scholar
• Taverna S, Giallombardo M, Pucci M, Flugy A, Manno M, Raccosta S, et al. Curcumin inhibits in vitro and in vivo chronic myelogenous leukemia cells growth: a possible role for exosomal disposal of miR-21. Oncotarget. 2015; 6:21918–21933.
   Web of Science ®Google Scholar
• Bose S, Panda AK, Mukherjee S, Sa G. Curcumin and tumor immune-editing: resurrecting the immune system. Cell Div. 2015;10:6.
   PubMed Web of Science ®Google Scholar
• Shehzad A, Lee YS. Molecular mechanisms of curcumin action: signal transduction. Biofactors. 2013;39:27–36.
   PubMed Web of Science ®Google Scholar
• Lee AY, Fan CC, Chen YA, Cheng CW, Sung YJ, Hsu CP, et al. Curcumin inhibits invasiveness and epithelial-mesenchymal transition in oral squamous cell carcinoma through reducing matrix metalloproteinase 2, 9 and modulating p53-E-cadherin pathway. Integr Cancer Ther. 2015;14:484–490.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Chen H, Xu C, Song L, Huang L, Lai Y, et al. Curcumin inhibits tumor epithelial-mesenchymal transition by downregulating the Wnt signaling pathway and upregulating NKD2 expression in colon cancer cells. Oncol Rep. 2016;35:2615–2623.
   Google Scholar
• Zhang L, Cheng X, Gao Y, Zhang C, Bao J, Guan H, et al. Curcumin inhibits metastasis in human papillary thyroid carcinoma BCPAP cells via down-regulation of the TGF-β/Smad2/3 signaling pathway. Exp Cell Res. 2016;341:157–165.
   PubMed Web of Science ®Google Scholar
• Cai XZ, Wang J, Li XD, Wang GL, Liu FN, Cheng MS, et al. Curcumin suppresses proliferation and invasion in human gastric cancer cells by downregulation of PAK1 activity and cyclin D1 expression. Cancer Biol Ther. 2009;8:1360–1368.
   PubMed Web of Science ®Google Scholar
• Yang CL, Liu YY, Ma YG, Xue YX, Liu DG, Ren Y, et al. Curcumin blocks small cell lung cancer cells migration, invasion, angiogenesis, cell cycle and neoplasia through Janus kinase-STAT3 signalling pathway. PLoS One. 2012;7:e37960.
   PubMed Web of Science ®Google Scholar
• Hu B, Sun D, Sun C, Sun YF, Sun HX, Zhu QF, et al. A polymeric nanoparticle formulation of curcumin in combination with sorafenib synergistically inhibits tumor growth and metastasis in an orthotopic model of human hepatocellular carcinoma. Biochem Biophys Res Commun. 2015;468:525–532.
   PubMed Web of Science ®Google Scholar
• Mundy GR. Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer. 2002;8:584–593.
   Web of Science ®Google Scholar
• Panahi Y, Saadat A, Beiraghdar F, Sahebkar A. Adjuvant therapy with bioavailability-boosted curcuminoids suppresses systemic inflammation and improves quality of life in patients with solid tumors: a randomized double-blind placebo-controlled trial. Phytother Res. 2014;28:1461–1467.
   PubMed Web of Science ®Google Scholar
• Patel BB, Sengupta R, Qazi S, Vachhani H, Yu Y, Rishi AK, et al. Curcumin enhances the effects of 5-fluorouracil and oxaliplatin in mediating growth inhibition of colon cancer cells by modulating EGFR and IGF-1R. Int. J. Cancer. 2008;122:267–273.
   PubMed Web of Science ®Google Scholar
• Aggarwal BB, Shishodia S, Takada Y, Banerjee S, Newman RA, Bueso-Ramos CE, et al. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice. Clin. Cancer Res. 2005;11:7490–7498.
   PubMed Web of Science ®Google Scholar
• Kunnumakkara AB, Guha S, Krishnan S, Diagaradjane P, Gelovani J, Aggarwal BB. Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products. Cancer Res. 2007;67:3853–3861.
   PubMed Web of Science ®Google Scholar
• Siddiqui RA, Harvey KA, Walker C, Altenburg J, Xu Z, Terry C, et al. Characterization of synergistic anti-cancer effects of docosahexaenoic acid and curcumin on DMBA-induced mammary tumorigenesis in mice. BMC Cancer. 2013;13:418.
   PubMed Web of Science ®Google Scholar
• Swamy MV, Citineni B, Patlolla JMR, Mohammed A, Zhang Y, Rao CV. Prevention and treatment of pancreatic cancer by curcumin in combination with omega-3 fatty acids. Nutr. Cancer 2008;60:81–89.
   PubMed Web of Science ®Google Scholar
• Hosseinimehr SJ, Hosseini SA. Radiosensitive effect of curcumin on thyroid cancer cell death induced by radioiodine-131. Interdiscip Toxicol. 2014;7:85–88.
   PubMedGoogle Scholar
• Xu D, Tian W, Shen H. P-gp upregulation may be blocked by natural curcuminoids, a novel class of chemoresistance-preventing agent. Mol Med Rep. 2013;7:115–121.
   PubMed Web of Science ®Google Scholar
• Sharma RA, Ireson CR, Verschoyle RD, Hill KA, Williams ML, Leuratti C, et al. Effects of dietary curcumin on glutation S-transferase and malondialdehyde-DNA adducts in rat liver and colon mucosa: relation with drug levels. Clin Cancer Res. 2001;7:1452–1458.
   PubMed Web of Science ®Google Scholar
• Townsend DM, Tew KD. The role of glutathione-S-transferase in anti-cancer drug resistance. Oncogene. 2003;22:7369–7375.
   PubMed Web of Science ®Google Scholar
• Xiao H, Xiao Q, Zhang K, Zuo X, Shrestha UK. Reversal of multidrug resistance by curcumin through FA/BRCA pathway in multiple myeloma cell line MOLP-2/R. Ann Hematol. 2010;89:399–404.
   PubMed Web of Science ®Google Scholar
• Noratto GD, Jutooru I, Safe S, Angel-Morales G, Mertens-Talcott SU. The drug resistance suppression induced by curcuminoids in colon cancer SW-480 cells is mediated by reactive oxygen species-induced disruption of the microRNA-27a-ZBTB10-Sp axis. Mol Nutr Food Res. 2013;57:1638–1648.
   PubMed Web of Science ®Google Scholar
• Allegra A, Alonci A, Penna G, Innao V, Gerace D, Rotondo F, et al. The cancer stem cell hypothesis: a guide to potential molecular targets. Cancer Invest. 2014;32:470–495.
   PubMed Web of Science ®Google Scholar
• Norris L, Karmokar A, Howells L, Steward WP, Gescher A, Brown K. The role of cancer stem cells in the anti-carcinogenicity of curcumin. Mol Nutr Food Res. 2013;57:1630–1637.
   PubMed Web of Science ®Google Scholar
• Wu L, Guo L, Liang Y, Liu X, Jiang L, Wang L. Curcumin suppresses stem-like traits of lung cancer cells via inhibiting the JAK2/STAT3 signaling pathway. Oncol Rep. 2015;34:3311–3317.
   PubMed Web of Science ®Google Scholar
• Mukherjee S, Mazumdar M, Chakraborty S, Manna A, Saha S, Khan P, et al. Curcumin inhibits breast cancer stem cell migration by amplifying the E-cadherin/β-catenin negative feedback loop. Stem Cell Res Ther. 2014;5(5):116.
   PubMed Web of Science ®Google Scholar
• Zhou Q, Ye M, Lu Y, Zhang H, Chen Q, Huang S, et al. Curcumin improves the tumoricidal effect of mitomycin C by Suppressing ABCG2 expression in stem cell-like breast cancer cells. PLoS One. 2015;10:e0136694.
   PubMed Web of Science ®Google Scholar
• Basak SK, Zinabadi A, Wu AW, et al. Liposome encapsulated curcumin-difluorinated (CDF) inhibits the growth of cisplatin resistant head and neck cancer stem cells. Oncotarget 2015; 6:18504–18517.
   PubMed Web of Science ®Google Scholar
• Ning X, Du Y, Ben Q, Huang L, He X, Gong Y, et al. Bulk pancreatic cancer cells can convert into cancer stem cells(CSCs) in vitro and 2 compounds can target these CSCs. Cell Cycle. 2016;15:403–412.
   PubMed Web of Science ®Google Scholar
• Botchkina GI, Zuniga ES, Rowehl RH, Park R, Bhalla R, Bialkowska AB, et al. Prostate cancer stem cell-targeted efficacy of a new-generation taxoid, SBT-1214 and novel polyenolic zinc-binding curcuminoid, CMC2.24. PLoS One. 2013;8:e69884.
   PubMed Web of Science ®Google Scholar
• James MI, Iwuji C, Irving G, Karmokar A, Higgins JA, Griffin-Teal N, et al. Curcumin inhibits cancer stem cell phenotypes in ex vivo models of colorectal liver metastases, and is clinically safe and tolerable in combination with FOLFOX chemotherapy. Cancer Lett. 2015;364:135–141.
   PubMed Web of Science ®Google Scholar
• Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: problems and promises. Mol Pharm. 2007;4:807–818.
   PubMed Web of Science ®Google Scholar
• Zlotogorski A, Dayan A, Dayan D, Chaushu G, Salo T, Vered M. Nutraceuticals as new treatment approaches for oral cancer - I: Curcumin. Oral Oncol. 2013;49:187–191.
   PubMed Web of Science ®Google Scholar
• Ravindranath V, Chandrasekhara N. Absorption and tissue distribution of curcumin in rats. Toxicology. 1980;16:259–265.
   PubMed Web of Science ®Google Scholar
• Kumar A, Ahuja A, Ali J, Baboota S. Conundrum and therapeutic potential of curcumin in drug delivery. Crit Rev Ther Drug Carrier Syst. 2010;27:279–312.
   PubMed Web of Science ®Google Scholar
• Dong Y, Yin S, Song X, Huo Y, Fan L, Ye M, et al. Involvement of ROS-p38-H2AX axis in novel curcumin analogues-induced apoptosis in breast cancer cells. Mol Carcinog. 2016;55:323–334.
   Web of Science ®Google Scholar
• Pati HN, Das U, Quail JW, Kawase M, Sakagami H, Dimmock JR. Cytotoxic 3,5-bis(benzylidene)piperidin-4-ones and N-acyl analogs displaying selective toxicity for malignant cells. Eur J Med Chem. 2008;43:1–7.
   PubMed Web of Science ®Google Scholar
• Sun A, Shoji M, Lu YJ, Liotta DC, Snyder JP. Synthesis of EF24-tripeptide chloromethyl ketone: a novel curcumin-related anticancer drug delivery system. J Med Chem. 2006;49:3153–3158.
   PubMed Web of Science ®Google Scholar
• Subramaniam D, May R, Sureban SM, Lee KB, George R, Kuppusamy P, et al. Diphenyl difluoroketone: a curcumin derivative with potent in vivo anticancer activity. Cancer Res. 2008;68:1962–1969.
   PubMed Web of Science ®Google Scholar
• Lagisetty P, Subramaniam D, Sahoo K, Anant S, Awasthi V. Anticancer Activity of an Imageable Curcuminoid 1-[2-Aminoethyl-(6-hydrazinopyridine-3-carbamidyl)-3,5-bis-(2-fluorobenzylidene)-4-piperidone (EFAH). Chem Biol Drug Des. 2012;79:194–201.
   PubMed Web of Science ®Google Scholar
• Mishra S, Narain U, Mishra R, Misra K. Design, development and synthesis of mixed bioconjugates of piperic acid-glycine, curcumin-glycine/alanine and curcumin-glycine-piperic acid and their antibacterial and antifungal properties. Bioorg. Med. Chem. 2005;13:1477–1486.
   PubMed Web of Science ®Google Scholar
• Kumar S, Narain U, Tripathi S, Misra K. Syntheses of curcumin bioconjugates and study of their antibacterial activities against β-lactamase-producing microorganisms. Bioconjugate Chem. 2001;12:464–469.
   PubMed Web of Science ®Google Scholar
• Ferrari E, Lazzari S, Marverti G, Pignedoli F, Spagnolo F, Saladini M. Synthesis, cytotoxic and combined cDDP activity of new stable curcumin derivatives. Bioorg. Med. Chem. 2009;17:3043–3052.
   PubMed Web of Science ®Google Scholar
• Wichitnithad W, Nimmannit U, Wacharasindhu S, Rojsitthisak P. Synthesis, characterization and biological evaluation of succinate prodrugs of curcuminoids for colon cancer treatment. Molecules 2011;16:1888–1900.
   PubMed Web of Science ®Google Scholar
• Kudo C, Yamakoshi H, Sato A, Ohori H, Ishioka C, Iwabuchi Y, et al. Novel curcumin analogs, GO-Y030 and GO-Y078, are multi-targeted agents with enhanced abilities for multiple myeloma. Anticancer Res. 2011;31:3719–3726.
   PubMed Web of Science ®Google Scholar
• Allegra A, Penna G, Alonci A, Rizzo V, Russo S, Musolino C. Nanoparticles in oncology: the new theragnostic molecules. Anticancer Agents Med Chem. 2011;11:669–686.
   PubMed Web of Science ®Google Scholar
• Say A, Desai H, Meer T. Solubility and dissolution rate enhancement of curcumin using kollidon VA64 by solid dispersion technique. Int. J. Pharm Tech Res. 2012;4:1054–1064.
   Google Scholar
• Kumar K, Rai AK. Development and evaluation of floating microspheres of curcumin. Trop. J. Pharm. Res. 2012;11:713–719.
   Web of Science ®Google Scholar
• Tsai YM, Chien CF, Lin LC, Tsai TH. Curcumin and its nano-formulation: The kinetics of tissue distribution & blood-brain-barrier penetration. Int. J. Pharm. 2011;2011:1–8.
   Google Scholar
• Shinde PY, Parve BS, Rawat S. Different approaches towards the solubility enhancement of drug: A review. World J. Pharm. Pharm. Sci. 2014;3:625–646.
   Google Scholar
• Yasuji T, Takeuchi H, Kawashima Y. Particle design of poorly water soluble drug substances using supercritical fluid technologies. Adv. Drug Deliv. Rev. 2008;60:388–398.
   PubMed Web of Science ®Google Scholar
• Dixit N. Floating drug delivery system. J. Curr. Pharm. Res. 2011;7:6–20.
   Google Scholar
• Setya S, Talegonkar S, Razdan BK. Nanoemulsions: Formulation methods and stability aspects. World J. Pharm. Pharm. Sci. 2014;3:2214–2228.
   Google Scholar
• Singh A, Garg G, Sharma PK. Nanospheres: A novel approach for targeted drug delivery system. Int. J. Pharm. Sci. Rev. Res. 2010;5:84–88.
   Google Scholar
• Shinde NC, Keskar NJ, Argade PD. Nanoparticles: Advances in drug delivery systems. Res. J. Pharm. Biol. Chem. Sci. 2012;3:922–929.
   Google Scholar
• Yang X, Li Z, Wang N, Li L, Song L, He T, et al. Curcumin-encapsulated polymeric micelles suppress the development of colon cancer in vitro and in vivo. Sci Rep. 2015;5:10322.
   PubMed Web of Science ®Google Scholar
• Wang K, Zhang T, Liu L, Wang X, Wu P, Chen Z, et al. Novel micelle formulation of curcumin for enhancing antitumor activity and inhibiting colorectal cancer stem cells. Int J Nanomedicine. 2012;7:4487–4497.
   PubMed Web of Science ®Google Scholar
• Chang R, Sun L, Webster TJ. Selective inhibition of MG-63 osteosarcoma cell proliferation induced by curcumin-loaded self-assembled arginine-rich-RGD nanospheres. Int J Nanomedicine. 2015;10:3351–3365.
   PubMed Web of Science ®Google Scholar
• Milano F, Mari L, van de Luijtgaarden W, Parikh K, Calpe S, Krishnadath KK. Nano-curcumin inhibits proliferation of esophageal adenocarcinoma cells and enhances the T cell mediated immune response. Front Oncol. 2013;3:137.
   PubMedGoogle Scholar
• Davis S, Weiss MJ, Wong JR, Lampidis TJ, Chen LB. Mitochondrial and plasma membrane potentials cause unusual accumulation and retention of rhodamine 123 b25y human breast adeno-carcinoma-derived MCF-7 cells. J Biol Chem. 1985;260:13844–13850.
   PubMed Web of Science ®Google Scholar
• Dairkee SH, Hackett AJ. Differential retention of rhodamine 123 by breast carcinoma and normal human mammary tissue. Breast Cancer Res Treat. 1991;18:57–61.
   PubMed Web of Science ®Google Scholar
• Reddy CA, Somepalli V, Golakoti T, Kanugula AK, Karnewar S, Rajendiran K, et al. Mitochondrial-targeted curcuminoids: a strategy to enhance bioavailability and anticancer efficacy of curcumin. PLoS ONE 2014;9:e89351.
   PubMed Web of Science ®Google Scholar
• Sadeghizadeh M, Ranjbar B, Damaghi M. Dendrosomes as novel gene porters-III. J Chem Technol Biotechnol. 2008;83:912–920.
   Web of Science ®Google Scholar
• Sarbolouki MN, Sadeghizadeh M, Yaghoobi MM. Dendrosomes: a novel family of vehicles for transfection and therapy. J Chem Technol Biotechnol. 2000;75:919–922.
   Web of Science ®Google Scholar
• Babaei E, Feizi MAH, Najafi F, Hashemi SM. Dendrosomal curcumin significantly suppresses cancer cell proliferation in vitro and in vivo. Int Immunopharmacol. 2012;12:226–234.
   PubMed Web of Science ®Google Scholar
• Alizadeh AM, Khaniki M, Azizian S, Mohaghgheghi MA, Sadeghizadeh M, Najafi F. Chemoprevention of azoxymethane-initiated colon cancer in rat by using a novel polymeric nanocarrier-curcumin. Eur J Pharmacol. 2012;689:226–232.
   PubMed Web of Science ®Google Scholar
• Mirgani MT, Isacchi B, Sadeghizadeh M, Marra F, Bilia AR, Mowla SJ, et al. Dendrosomal curcumin nanoformulation downregulates pluripotency genes via miR-145 activation in U87MG glioblastoma cells. Int J Nanomedicine 2014;9:403–417.
   PubMed Web of Science ®Google Scholar
• Khan MA, Akhtar N, Sharma V, Pathak K. Product development studies on sonocrystallized curcumin for the treatment of gastric cancer. Pharmaceutics 2015;7:43–63.
   PubMed Web of Science ®Google Scholar
• Bayomi SM, El-Kashef HA, El-Ashmawy MB, Nasr MN, El-Sherbeny MA, Abdel-Aziz NI, et al. Synthesis and biological evaluation of new curcumin analogues as antioxidant and antitumor agents: molecular modeling study. Eur J Med Chem. 2015;101:584–594.
   PubMed Web of Science ®Google Scholar
• Fiala M. Curcumin and Omega-3 Fatty Acids Enhance NK cell-induced apoptosis of pancreatic cancer cells but curcumin inhibits interferon-γ production: benefits of omega-3 with curcumin against cancer. Molecules 2015;20:3020–3026.
   PubMed Web of Science ®Google Scholar
• Attari F, Zahmatkesh M, Aligholi H, Mehr SE, Sharifzadeh M, Gorji A, et al. Curcumin as a double-edged sword for stem cells: dose, time and cell type-specific responses to curcumin. Daru. 2015;23:33.
   PubMed Web of Science ®Google Scholar
• Asti M, Ferrari E, Croci S, Atti G, Rubagotti S, Iori M, et al. Synthesis and characterization of (68)Ga-labeled curcumin and curcuminoid complexes as potential radiotracers for imaging of cancer and Alzheimer's disease. Inorg Chem. 2014;53:4922–4933.
   PubMed Web of Science ®Google Scholar